Plasma Renin Activity Predicts the Improvement in Resistant Hypertension after Percutaneous Transluminal Renal Artery Angioplasty

• Published in: Internal Medicine Vol. 55; no. 23; pp. 3421 - 3426
• Main Authors: Daidoji, Hyuma, Tamada, Yoshiaki, Suzuki, Saya, Watanabe, Ken, Shikama, Taku, Kikuchi, Yoku, Kato, Shigehiko, Takahashi, Katsuaki, Fukui, Akio, Matsui, Motoyuki, Yahagi, Tomoyasu, Goto, Toshikazu
• Format: Journal Article
• Language: English
• Published: Japan The Japanese Society of Internal Medicine 01.01.2016
• Subjects: Aged; Aged, 80 and over; Angioplasty - methods; Antihypertensive Agents - therapeutic use; Blood Pressure; Female; Humans; Hypertension, Renovascular - surgery; Kidney - physiopathology; Male; Middle Aged; Original; percutaneous renal artery angioplasty; plasma renin activity; Renal Artery; Renal Artery Obstruction - surgery; renal artery stenosis; Renin - blood
• ISSN: 0918-2918; 1349-7235
• DOI: 10.2169/internalmedicine.55.7312

Objective Percutaneous transluminal renal artery angioplasty (PTRA) has been recommended for the treatment of renovascular resistant hypertension. However, large randomized trials have reported that PTRA did not improve the outcomes compared with optimal medical therapy in patients with renal artery stenosis (RAS). It is important to identify patients with renovascular hypertension who are likely to respond to PTRA. We herein examined whether or not the plasma renin activity (PRA) could predict the improvement in resistant hypertension after PTRA for RAS. Methods and Results A total of 40 patients (mean age: 63±15 years) with unilateral RAS who received PTRA for resistant hypertension were enrolled in this study. Twenty-two (55%) patients experienced a significant reduction in their blood pressure while using few antihypertensive agents at the 3-month follow up. The median PRA was significantly higher in patients using few antihypertensive agents than in those using more [4.2 ng/mL/hr, interquartile range (IQR) 2.6-8.0 vs. 0.8 ng/mL/hr, IQR 0.4-1.7, p<0.001]. To predict the improvement in hypertension after PTRA, a receiver operating characteristic analysis determined the optimal cut-off value of PRA to be 2.4 ng/mL/hr. A multivariate logistic regression analysis showed that higher PRA (>2.4 ng/mL/hr) was an independent predictor of the improvement in hypertension after PTRA (odds ratio: 22.3, 95% confidence interval: 2.17 to 65.6, p<0.01). Conclusion These findings suggest that the evaluation of preoperative PRA may be a useful tool for predicting the improvement in resistant hypertension after PTRA for patients with RAS.